Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000242782 | SCV000313405 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Gene |
RCV001582872 | SCV001812526 | likely benign | not provided | 2021-10-06 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV002278208 | SCV002565180 | likely benign | Ehlers-Danlos syndrome | 2021-01-25 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002374427 | SCV002688569 | benign | Cardiovascular phenotype | 2019-07-05 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV002500915 | SCV002809072 | benign | Ehlers-Danlos syndrome due to tenascin-X deficiency; Vesicoureteral reflux 8 | 2021-07-07 | criteria provided, single submitter | clinical testing |